AvantGuard
PrivateLast Round
Seed
Jun 24, 2026
Total Funding Raised
$14.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AvantGuard operates in Healthcare & Life Sciences and is based in Ithaca, New York. Its latest recorded funding round was a Seed round in June 2026.
AvantGuard is a healthcare company that develops antimicrobial technologies, including its flagship molecule Avantamine, designed to combat pathogens on surfaces and skin.
Sector
Healthcare & Life Sciences
Verticals
Advanced Materials, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AvantGuard Comparables
Compare AvantGuard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kismet Technologies | 79% | |
| Allied BioScience | 79% | |
| Kastus Technologies | 62% |
For institutional investors. Book with your work email.
AvantGuard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2026 | ||||
| Grant | Nov 10, 2025 | ||||
| Grant | Jun 7, 2023 | ||||
| Seed | May 11, 2023 | ||||
| Grant | Apr 19, 2023 | ||||
Grant | Sep 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AvantGuard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Launch NY | Seed |
| NIH RADx | Grant |
| Blue Ledge Capital | Seed |
| Empire State Development | Grant |
| FuzeHub | Grant |
| Red Bear Ventures | Seed, Angel |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 64% MoM.
- Jun 24, 2026
$1.7M seed round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 13, 2026
AvantGuard, Inc. closes an oversubscribed $1.7M Seed round from new investors and existing shareholders in New York in Jun '26.
For institutional investors. Book with your work email.
AvantGuard Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AvantGuard's valuation, stock price, and market status.
Is AvantGuard a public or private company?
AvantGuard is a private company.
What is the current stock price of AvantGuard?
AvantGuard is a private company, so its shares have no public market price. Caplight tracks AvantGuard's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AvantGuard worth (valuation)?
Valuation information for AvantGuard is not publicly available.
Can I buy AvantGuard stock?
AvantGuard shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AvantGuard's last funding round?
AvantGuard's most recent funding round was Seed on June 24, 2026.
Who are the main investors in AvantGuard?
Key investors in AvantGuard include NIH RADx, Blue Ledge Capital.
Will AvantGuard IPO soon?
No public IPO plans have been announced for AvantGuard.
How can I track AvantGuard secondary market activity?
Caplight tracks bids, offers, and trades in AvantGuard's shares on secondary markets.